http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100559306-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0819 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-185 |
filingDate | 2001-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2006-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2006-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100559306-B1 |
titleOfInvention | Peptide derivatives and their pharmaceutically acceptable salts, preparation methods thereof and uses thereof |
abstract | The present invention, the formulan n n Formula In n n [Wherein X represents -CHOH- or -CO-, R 1 and R 2 represent a hydrogen atom or a substituted oxycarbonyl group, R 3 represents a substituted oxycarbonyl group, R 4 represents a hydroxyl group, a lower alkoxy group, a substituent The piperazinyl group which may have etc. is shown, R < 5> represents the R group side chain of the (alpha) -amino acid which may be protected by the protecting group, and R < 6> represents a hydroxyl group, a lower alkoxy group, etc. group. m represents 0 or 1, n represents an integer of 2 to 6; and a pharmaceutically acceptable salt thereof, a method for preparing the same, and a use thereof.n n n Peptide Derivatives, Periodontal Medicines, Oral Compositions, Lysine-Gynephine Inhibitors |
priorityDate | 2000-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.